KAREN SLEEMAN: Open Payments
NPI 1275532228 · JAMESTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 18 payments from 12 companies in 2025. Trend: 2023 $1,010 · 2024 $453 · 2025 $391
Food & beverage: $336Education: $55
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $94 |
| Pharmacosmos Therapeutics Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| PharmaEssentia USA Corporation | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| SpringWorks Therapeutics, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
Products named: MONOFERRIC, RYBREVANT, CALQUENCE, KEYTRUDA, ORGOVYX, BESREMI, OPDIVO, DARZALEX.
Industry payments across NY — which companies pay providers there.
